How much does Notts Pharma UK Ltd make?

Notts Pharma UK Ltd reported revenue of £16.3m and a loss of £4.7m in the year to 31 Dec 2025, according to its accounts filed at Companies House.

How many employees does Notts Pharma UK Ltd have?

Notts Pharma UK Ltd reported an average of 163 employees in the year to 31 Dec 2025.

Is Notts Pharma UK Ltd profitable?

No — Notts Pharma UK Ltd reported a loss of £4.7m in the year to 31 Dec 2025.

Company No. 03397582 · Incorporated 3 Jul 1997

Notts Pharma UK Ltd

Registered name: NOTTS PHARMA UK LTD

Part of Haverhill UK Holdco Limited group

Notts Pharma UK Ltd made £16.3m revenue and a £4.7m loss in the year to 31 Dec 2025.

Notts Pharma UK Ltd’s revenue was £16.3m in the year to 31 Dec 2025, with a loss of £4.7m and 163 employees. The company is classified under “other research and experimental development on natural sciences and engineering” and is based in Nottingham; we hold 2 years of its filed accounts.

Full P&L filedSection M · Professional, scientific and technical activitiesSIC 72190Other research and experimental development on natural sciences and engineering

Status: Active
Location: Nottingham, East Midlands
Age: 29 yrs · since 1997
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “Catalent UK Supply Chain Limited.”

Latest accounts · year to 31 Dec 2025

Key figures

Revenue

£16.3m

Growth —

Profit

−£4.7m

Growth —

Profit margin

−28.7%

Gross 43%

Employees

163

Change —

Profit / employee

−£28.8k

Revenue/employee £100k

Profitable streak

0yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

2 filed years

Financial history

Multi-year financials, oldest to newest
Year to	30 Jun 2024	31 Dec 2025
Disclosure	Full P&L	Full P&L
Profit & loss
Revenue (turnover)	£14.5m	£16.3m
Cost of sales	£7.8m	£9.3m
Gross profit	£6.7m	£7m
Operating profit	−£1.8m	−£4m
Profit before tax	−£2.1m	−£4.4m
Profit after tax	−£2.3m	−£4.7m
Profit (best available)	−£2.3m	−£4.7m
Staff costs	£9.7m	£14.4m
Employees (average)	185	163
Ratios
Profit margin	−15.5%	−28.7%
Gross margin	46%	43%
Revenue per employee	£78.5k	£100k
Profit per employee	−£12.2k	−£28.8k
Balance sheet — indirect signals, not revenue
Cash at bank	£1.9m	£1.6m
Net assets	£8.7m	£4m
Fixed assets	£10.1m	£10.1m
Current assets	£7.6m	£5.6m
Debtors	£1.9m	£1.3m
Deferred income	£1.4m	£563k
Source	FullAccounts · bulk data Aug 2026	FullAccounts · bulk data Aug 2026

Derived from the latest filing

How the business works

Profit margin: −28.7%; Profit ÷ revenue.
Gross margin: 43%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: £100k; Revenue ÷ average employees.
Profit per employee: −£28.8k; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: 61.9%; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: 3.4%; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: 8%; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: —; Now £4m
Cash at bank: —; Now £1.6m
Headcount: —; Now 163
Deferred income: —; Now £563k
Fixed assets: —; Now £10.1m

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

Haverhill UK Holdco Limitedultimate parent75–100%
Notts Pharma UK Ltdthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (1)

HVL Pharma UK LtdFigures not disclosed

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Dec 2025 (profit −£4.7m), from the Companies House accounts bulk data published Aug 2026. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.